Skip to main content

 Related scientific articles (all)

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Authors : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Year : 2021
Journal : Acta oncologica
Pages : 1-5

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

Authors : Navez J, Bouchart C, Lorenzo D, Bali MA, Closset J, Van Laethem JL
Year : 2021
Journal : Ann Surg Oncol

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Authors : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N
Year : 2021
Journal : EJNMMI Phys
Volume : 8
Pages : 9

EUS-guided placement of fiducial markers for stereotactic body radiation therapy in pancreatic cancer: feasibility, security and a new quality score.

Authors : Figueiredo M, Bouchart C, Moretti L, Mans L, Engelholm JL, Bali MA, Van Laethem JL, Eisendrath P
Year : 2021
Journal : Endosc Int Open
Volume : 9
Pages : E253-E257

Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma.

Authors : Giraud P, Racadot S, Vernerey D, Goldstein D, Glimelius B, Van Houtte P, Gubanski M, Spry N, Van Laethem JL, Hammel P, Huguet F
Year : 2021
Journal : Int J Radiat Oncol Biol Phys

Predictive value of neutrophils count for local tumor control after chemoradiotherapy in patients with locally advanced pancreatic carcinoma.

Authors : Schernberg A, Vernerey D, Goldstein D, Van Laethem JL, Glimelius B, Van Houtte P, Bonnetain F, Louvet C, Hammel P, Huguet F
Year : 2021
Journal : Int J Radiat Oncol Biol Phys

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Authors : Bouchart C, Navez J, Closset J, Hendlisz A, Van Gestel D, Moretti L, Van Laethem JL
Year : 2020
Journal : Ther Adv Med Oncol
Volume : 12
Pages : 1758835920936093

Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO).

Authors : Salembier C, De Hertogh O, Daisne JF, Palumbo S, Van Gestel D
Year : 2020
Journal : Radiother Oncol
Volume : 150
Pages : 245-252

ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.

Authors : Le Pechoux C, Faivre-Finn C, Ramella S, McDonald F, Manapov F, Putora PM, Slotman B, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Van Houtte P, Nestle U
Year : 2020
Journal : Radiother Oncol
Volume : 152
Pages : 89-95

Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise.

Authors : Glatzer M, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost EGC, Dahele MR, Slotman BJ, Ramella S, Pöttgen C, Peeters STH, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Putora PM
Year : 2020
Journal : Radiother Oncol
Volume : 150
Pages : 26-29

Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.

Authors : Mané M, Benkhaled S, Dragan T, Paesmans M, Beauvois S, Lalami Y, Szturz P, Gaye PM, Vermorken JB, Van Gestel D
Year : 2020
Journal : Oncologist

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts.

Authors : Putora PM, Fischer GF, Früh M, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Pechoux C, Ramella S, Belderbos J, Slotman BJ, Troost EGC, Peeters S, Widder J, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, OBrien M, Paz Ares L, de Marinis F, Westeel V, De Ruysscher D
Year : 2020
Journal : Radiother Oncol
Volume : 149
Pages : 84-88

Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine.

Authors : Glatzer M, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost EGC, Slotman BJ, Ramella S, Pöttgen C, Peeters STH, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Süveg K, Putora PM
Year : 2020
Journal : Radiother Oncol
Volume : 154
Pages : 269-273

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity.

Authors : Szturz P, Van Laer C, Simon C, Van Gestel D, Bourhis J, Vermorken JB
Year : 2020
Journal : Front Oncol
Volume : 10
Pages : 688

Development of Staffing, Workload and Infrastructure in Member Departments of the European Organisation for Research and Treatment of Cancer (EORTC) Radiation Oncology Group.

Authors : Willmann J, Poortmans P, Fillipo Monti A, Grant W, Clementel E, Corning C, Reynaert N, Hurkmans CW, Andratschke N
Year : 2020
Journal : Radiother Oncol

PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.

Authors : De Bruycker A, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte FX, Papachristofilou A, Scorsetti M, Shelan M, Siva S, Ameye F, Guckenberger M, Heikkilä R, Putora PM, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ost P
Year : 2020
Journal : BMC Cancer
Volume : 20
Pages : 406

Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Authors : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N
Year : 2020
Journal : EJNMMI Phys
Volume : 7
Pages : 75

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.

Authors : Dirix P, Strijbos M, den Mooter TV, Liefhooghe N, Bruwaene SV, Uvin P, Ghysel C, Ost D, Schatteman P, Bral S, Engels B, den Begin RV, Otte FX, Roumeguere T, Palumbo S, Neybuch Y, Fonteyne V, Ost P, Dirix L
Year : 2020
Journal : Future Oncol
Volume : 16
Pages : 1083-1189

Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature.

Authors : Benkhaled S, Mané M, Jungels C, Shumelinsky F, Aubain NS, Van Gestel D
Year : 2020
Journal : Cancer Treat Res Commun
Volume : 26
Pages : 100282

The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.

Authors : Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte FX, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A, Semac I, Vanhoutte F, Goetghebeur E, Reynders D, Ost P
Year : 2020
Journal : Eur Urol Focus